THE TRANSFORMING AND SUPPRESSOR FUNCTIONS OF P53 ALLELES - EFFECTS OF MUTATIONS THAT DISRUPT PHOSPHORYLATION, OLIGOMERIZATION AND NUCLEAR TRANSLOCATION

被引:140
作者
SLINGERLAND, JM
JENKINS, JR
BENCHIMOL, S
机构
[1] UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M4X 1K9,ONTARIO,CANADA
[2] MARIE CURIE SKLODOWSKA MEM INST,OXTED RH8 0TL,SURREY,ENGLAND
关键词
NUCLEAR TRANSLOCATION; OLIGOMERIZATION; P53; SUPPRESSION; TRANSFORMATION;
D O I
10.1002/j.1460-2075.1993.tb05744.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutant p53 alleles that have a recessive phenotype in human tumors can, in cooperation with an activated H-ras gene, transform rat embryo fibroblasts (REFs). Mutant p53 proteins differ from wild type, and from each other in conformation, localization and transforming potential. Missense mutations in codons 143, 175 and 275 confer strong transforming potential. A serine 135 p53 mutant has an intermediate transforming potential, while the histidine codon 273 allele transforms weakly, if at all. In contrast to the wild type p53 gene, mutant p53 alleles with strong transforming ability cannot suppress the transformation of REFs by other oncogenes. The His273 allele retains partial suppressor function in this assay. The relevance of p53 oligomerization, phosphorylation and nuclear translocation to the transforming potential of mutant p53 and to wild type p53 suppressor function were examined. The inability of mutant p53 polypeptides to form homodimers correlates with loss of transforming function. Monomeric variants of wild type p53 protein, however, retain the ability to suppress focus formation. Phosphorylation of serine residues 315 and 392 is not required for the transforming function of mutant p53, nor is serine 315 required for suppressor function when these alleles are constitutively expressed in REF assays. Nuclear translocation-defective mutant and wild type p53 proteins retain transforming and suppressor function in REF assays.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 65 条
  • [1] ADDISON C, 1990, ONCOGENE, V5, P423
  • [2] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [3] BAKER SJ, 1990, CANCER RES, V50, P7717
  • [4] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [5] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [6] HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2
    BISCHOFF, JR
    FRIEDMAN, PN
    MARSHAK, DR
    PRIVES, C
    BEACH, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4766 - 4770
  • [7] GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE
    CHEN, PL
    CHEN, YM
    BOOKSTEIN, R
    LEE, WH
    [J]. SCIENCE, 1990, 250 (4987) : 1576 - 1580
  • [8] CHENG J, 1992, CANCER RES, V52, P222
  • [9] RB AND THE CELL-CYCLE - ENTRANCE OR EXIT
    COOPER, JA
    WHYTE, P
    [J]. CELL, 1989, 58 (06) : 1009 - 1011
  • [10] CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1